|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61K 38/39 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 37/02 | (2006.01) | ||
| C07K 14/78 | (2006.01) |
| (11) | Number of the document | 1019078 |
| (13) | Kind of document | T |
| (96) | European patent application number | 98917896.7 |
| Date of filing the European patent application | 1998-04-14 | |
| (97) | Date of publication of the European application | 2000-07-19 |
| (45) | Date of publication and mention of the grant of the patent | 2003-07-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE9800/682 |
| Date | 1998-04-14 |
| (87) | Number | WO 9804/6253 |
| Date | 1998-10-22 |
| (30) | Number | Date | Country code |
| 9701409 | 1997-04-15 | SE |
| (72) |
HEINEGARD, Dick Lunds Universitet Dept. of Cell, SE
LORENTZEN, Johnny, C., SE
KLARESKOG, Lars, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | USE OF CARTILAGE OLIGOMERIC MATRIX PROTEIN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS |
| USE OF CARTILAGE OLIGOMERIC MATRIX PROTEIN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS |